Patent details

Basic Information

Publication number:

EP2846780

PCT Application Number:

US2013038770

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP137222170

PCT Publication Number:

WO2013169520

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SOLUBILIZED CAPSULE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-{[(2S,4R)-4-(7-CHLORO-4METHOXYISOQUINOLIN-1-YLOXY)-2-({(1R,2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ETHENYLCYCLOPROPYL}CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE

French Title of Invention:

FORMULATION DE CAPSULE SOLUBILISÉE DE 1,1-DIMÉTHYLÉTHYL[(1S)-1-{[(2S,4R)-4-(7-CHLORO-4-MÉTHOXYISOQUINOLIN-1-YLOXY)-2-({(1R,2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ÉTHÉNYLCYCLOPROPYL}CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMÉTHYLPROPYL]CARBAMATE

German Title of Invention:

SOLUBILISIERTE KAPSELFORMULIERUNG VON 1,1-DIMETHYLETHYL-[(1S)-1-{[(2S,4R)-4-(7-CHLOR-4METHOXYISOCHINOLIN-1-YLOXY)-2-({(1R,2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ETHENYLCYCLOPROPYL}CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMAT

SPC Number:

Dates

Filing date:

30/04/2013

Grant date:

18/07/2018

EP Publication Date:

18/03/2015

PCT Publication Date:

14/11/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/07/2018

EP B1 Publication Date:

18/07/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

30/04/2020

Expiration date:

30/04/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/01/2019

 

 

Name:

Bristol-Myers Squibb Holdings Ireland Unlimited Company

Address:

Hinterbergstrasse 16, 6312, Steinhausen, Switzerland (CH)

History of Owners

From:

11/07/2018

To:

23/01/2019

Name:

Bristol-Myers Squibb Holdings Ireland

Address:

Hinterbergstrasse 16, Steinhausen, Switzerland (CH)

Agent

Name:

MARKS & CLERK LLP

From:

03/08/2018

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

Name:

PERRONE, Robert Kevin

Address:

United States (US)

Priority

Priority Number:

201261643454 P

Priority Date:

07/05/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/48; A61K 31/4709; A61P 31/14;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2019/02

Publication date:

22/02/2019

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:

201829

Publication date:

18/07/2018

Description:

Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20190000045A

Date Registered:

23/01/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Bristol-Myers Squibb Holdings Ireland Unlimited Company

Address:

Hinterbergstrasse 16, 6312, Steinhausen, Switzerland (CH)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

09/04/2019

Last Annual Fee Paid Number:

7

Last Annual Fee Paid Amount:

82 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages
23/01/2019	Outgoing Correspondence	1
09/08/2018	Outgoing Correspondence	1
23/01/2019	Request For Change	6
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56